Mitigating the risk of radiation-induced cancers: limitations and paradigms in drug development
Stephen Yoo(Cedars-Sinai Medical Center), C. Norman Coleman(Unknown), Tom C. Hu(Biomedical Advanced Research and Development Authority), John D. Boice(Vanderbilt University), Pataje G.S. Prasanna(Stony Brook University), Ann R. Kennedy(University of Pennsylvania), Alla Shapiro(Center for Drug Evaluation and Research), Brian R. Moyer(Biomedical Advanced Research and Development Authority), Timothy J. Jorgensen(Georgetown University), Michael Fenech(Wine Australia), Marcy B. Grace(Biomedical Advanced Research and Development Authority), Gary J. Kelloff(Unknown)
Cited by 223
Related Papers
Cytokinesis-block micronucleus cytome assay
|Nature Protocols|2007|2k
Measurement of micronuclei in lymphocytes
|Mutation Research/Environmental Mutagenesis and Related Subjects|1985|1.8k
HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures
|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2002|1.4k
Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells
|Mutagenesis|2010|1.2k
Biomarkers of Nutrition for Development—Folate Review
|Journal of Nutrition|2015|1.1k